13711-22-3 Usage
Uses
Used in Organic Synthesis:
6-Chloro-1,4-dimethyl-2-nitrobenzene is utilized as an intermediate in organic synthesis, playing a crucial role in the formation of various chemical compounds.
Used in Pharmaceutical Production:
In the pharmaceutical industry, 6-CHLORO-1,4-DIMETHYL-2-NITROBENZENE is used as a key intermediate for the production of a range of pharmaceuticals, contributing to the development of new medications.
Used in Agrochemical Production:
6-CHLORO-1,4-DIMETHYL-2-NITROBENZENE also serves as an intermediate in the manufacturing process of various agrochemicals, supporting agricultural practices by enhancing crop protection and yield.
Used in Dye and Pigment Manufacturing:
6-Chloro-1,4-dimethyl-2-nitrobenzene is employed as a raw material in the production of dyes and pigments, contributing to the coloration of a wide array of products in different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 13711-22-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,7,1 and 1 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 13711-22:
(7*1)+(6*3)+(5*7)+(4*1)+(3*1)+(2*2)+(1*2)=73
73 % 10 = 3
So 13711-22-3 is a valid CAS Registry Number.
13711-22-3Relevant academic research and scientific papers
Bicyclic modulators of androgen receptor function
-
, (2008/06/13)
The invention provides for a pharmaceutical composition capable of modulating the androgen receptor comprising a compound of formula I wherein the substitutents are as described herein. Further provided are methods of using such compounds for the treatment of nuclear hormone receptor-associated conditions, such as age related diseases, for example sarcopenia. Also provided are pharmaceutical compositions containing such compounds and processes for preparing some of the compounds of the invention.
BICYCLIC MODULATORS OF ANDROGEN RECEPTOR FUNCTION
-
, (2008/06/13)
The invention provides compounds according to formula I wherein the substitutents are as described herein. Further provided are methods of using such compounds for the treatment of nuclear hormone receptor-associated conditions, such as age related diseases, for example sarcopenia. Also provided are pharmaceutical compositions containing such compounds and processes for preparing some of the compounds of the invention.
